HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jens Huober Selected Research

Operative Surgical Procedures

10/2021AGO Recommendations for the Surgical Therapy of the Axilla After Neoadjuvant Chemotherapy: 2021 Update.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jens Huober Research Topics

Disease

156Breast Neoplasms (Breast Cancer)
04/2024 - 01/2002
70Neoplasms (Cancer)
01/2024 - 01/2002
20Pathologic Complete Response
11/2023 - 12/2004
10Triple Negative Breast Neoplasms
04/2024 - 06/2014
7Diarrhea
01/2021 - 12/2004
7Ovarian Neoplasms (Ovarian Cancer)
11/2015 - 12/2006
6Circulating Neoplastic Cells
01/2024 - 05/2010
5Neutropenia
01/2023 - 07/2013
5Neoplasm Metastasis (Metastasis)
10/2021 - 01/2012
4Ovarian Epithelial Carcinoma
08/2012 - 12/2006
3Leukopenia
01/2023 - 11/2017
3Disease Progression
11/2021 - 01/2011
3Carcinoma (Carcinomatosis)
10/2017 - 03/2004
3Infections
07/2015 - 01/2012
3Febrile Neutropenia
01/2012 - 12/2004
2Pneumonia (Pneumonitis)
01/2023 - 01/2021
2Interstitial Lung Diseases (Interstitial Lung Disease)
01/2021 - 01/2010
2Fatigue
12/2020 - 06/2016
2Anemia
12/2020 - 01/2006
2Cardiotoxicity
04/2018 - 04/2010
2Vomiting
06/2016 - 04/2007
2Thrombocytopenia (Thrombopenia)
06/2014 - 07/2013
2Residual Neoplasm
10/2013 - 12/2006
2Exanthema (Rash)
07/2013 - 02/2012
2Hand-Foot Syndrome
01/2012 - 04/2010
2Inflammatory Breast Neoplasms
12/2011 - 01/2010
1Lymphatic Metastasis
02/2024
1Convalescence
01/2022

Drug/Important Bio-Agent (IBA)

42Hormones (Hormone)IBA
04/2024 - 04/2008
31Trastuzumab (Herceptin)FDA Link
02/2024 - 06/2006
23taxaneIBA
10/2023 - 04/2007
21AnthracyclinesIBA
01/2021 - 04/2007
20Paclitaxel (Taxol)FDA LinkGeneric
11/2023 - 01/2006
20Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 04/2008
19human ERBB2 proteinIBA
01/2023 - 01/2009
18Epirubicin (Ellence)FDA LinkGeneric
01/2022 - 12/2004
13ErbB Receptors (EGF Receptor)IBA
01/2024 - 04/2010
12abemaciclibIBA
04/2024 - 11/2017
12Lapatinib (GW572016)FDA Link
01/2024 - 04/2008
12Docetaxel (Taxotere)FDA Link
12/2020 - 12/2004
11Biomarkers (Surrogate Marker)IBA
11/2023 - 12/2004
11Phenobarbital (Luminal)FDA Link
11/2023 - 11/2010
10Bevacizumab (Avastin)FDA Link
01/2020 - 04/2008
9Capecitabine (Xeloda)FDA Link
11/2023 - 04/2008
8Carboplatin (JM8)FDA LinkGeneric
01/2022 - 09/2010
5pertuzumabIBA
02/2024 - 07/2015
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022 - 04/2008
5Messenger RNA (mRNA)IBA
01/2022 - 02/2013
5liposomal doxorubicin (Doxil)FDA Link
01/2022 - 01/2010
5Aromatase InhibitorsIBA
06/2021 - 12/2004
5PlatinumIBA
06/2014 - 04/2007
4130-nm albumin-bound paclitaxelIBA
11/2023 - 10/2015
4Proteins (Proteins, Gene)FDA Link
11/2023 - 01/2016
4TamoxifenFDA LinkGeneric
08/2022 - 04/2007
4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
4Estrogen ReceptorsIBA
11/2021 - 11/2014
4Fluorouracil (Carac)FDA LinkGeneric
12/2020 - 10/2015
3Ado-Trastuzumab EmtansineIBA
01/2022 - 01/2016
3Diphosphonates (Bisphosphonates)IBA
08/2021 - 10/2013
3Progesterone Receptors (Progesterone Receptor)IBA
06/2021 - 11/2014
3Poly(ADP-ribose) Polymerase InhibitorsIBA
04/2020 - 06/2011
3ParaffinIBA
01/2020 - 10/2014
3DNA (Deoxyribonucleic Acid)IBA
01/2020 - 10/2017
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2015 - 04/2008
3GemcitabineFDA Link
09/2010 - 12/2004
2Epidermal Growth Factor (EGF)IBA
04/2024 - 12/2023
2ribociclibIBA
12/2023 - 11/2021
2DenosumabFDA Link
11/2023 - 01/2022
2Ibandronic Acid (Boniva)FDA Link
11/2023 - 10/2013
2IceIBA
11/2023 - 10/2015
2Immunoconjugates (Immunoconjugate)IBA
01/2022 - 01/2021
2Zoledronic Acid (Zometa)FDA Link
08/2021 - 10/2013
2Cyclin-Dependent Kinase 4IBA
01/2021 - 11/2017
2Fulvestrant (Faslodex)FDA Link
01/2021 - 11/2017
2AntidiarrhealsIBA
01/2021 - 01/2021
2Epoetin Alfa (Epogen)FDA Link
12/2020 - 07/2013
2Immune Checkpoint InhibitorsIBA
04/2020 - 01/2020
2Formaldehyde (Formol)FDA Link
01/2018 - 10/2014
2EverolimusFDA Link
02/2016 - 07/2013
2lonafarnib (SCH 66336)IBA
11/2015 - 08/2012
2Vinorelbine (Navelbine)FDA LinkGeneric
08/2013 - 04/2008
1durvalumabIBA
04/2024
1Letrozole (Femara)FDA LinkGeneric
12/2023
1Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA
11/2023
1Maytansine (Maitansine)IBA
10/2023
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2023
1LigandsIBA
01/2022
1CalciumIBA
01/2022
1atezolizumabIBA
01/2022

Therapy/Procedure

64Therapeutics
01/2024 - 12/2004
57Neoadjuvant Therapy
11/2023 - 12/2004
49Drug Therapy (Chemotherapy)
02/2024 - 12/2004
7Adjuvant Chemotherapy
08/2021 - 06/2010
6Aftercare (After-Treatment)
01/2020 - 01/2010
4Drug Tapering
04/2024 - 04/2007
3Combination Drug Therapy (Combination Chemotherapy)
01/2021 - 01/2009
3Segmental Mastectomy (Lumpectomy)
11/2018 - 12/2004
2Radiotherapy
02/2024 - 10/2021
2Immunotherapy
01/2022 - 12/2019
2Resistance Training
01/2022 - 06/2018